ID
45998
Beschrijving
Principal Investigator: Esteban Burchard, MD, MPH, University of California, San Francisco, CA, USA MeSH: Lung Diseases https://www.ncbi.nlm.nih.gov/projects/gap/cgi-bin/study.cgi?study_id=phs000920 This is a case-only pharmacogenetic study of bronchodilator drug response among racially admixed Latino children with asthma. Each participant had two spirometry measurements using the KoKo PFT System. With the first spirometry test, participant was administered with 4 puffs of HFA Albuterol. The second albuterol measurement was based on age, for participants under 16 years of age, additional 2 puffs were administered and for those over 16 years of age, additional 4 puffs were administered. The overall goal is to identify genetic factors which are predictive of drug response in children with asthma. The principal tools include a questionnaire and biological specimen collection. Participants are 8-21 years old at time of recruitment. Children with asthma have physician-diagnosed asthma, symptoms and medications. Comprehensive phenotypic data for GALAII study participants are available through dbGaP phs001180.
Link
Trefwoorden
Versies (1)
- 18-04-24 18-04-24 - Madita Rudolph
Houder van rechten
Esteban Burchard, MD, MPH, University of California, San Francisco, CA, USA
Geüploaded op
18 april 2024
DOI
Voor een aanvraag inloggen.
Licentie
Creative Commons BY 4.0
Model Commentaren :
Hier kunt u commentaar leveren op het model. U kunt de tekstballonnen bij de itemgroepen en items gebruiken om er specifiek commentaar op te geven.
Itemgroep Commentaren voor :
Item Commentaren voor :
U moet ingelogd zijn om formulieren te downloaden. AUB inloggen of schrijf u gratis in.
dbGaP phs000920 NHLBI TOPMed - NHGRI CCDG: Genes-Environments and Admixture in Latino Asthmatics (GALA II)
Eligibility Criteria
- StudyEvent: SEV1
- Eligibility Criteria
- The subject consent data table contains subject IDs, consent group information, subject aliases, and subject's sex.
- This subject sample mapping data table includes a mapping of study subject IDs to sample IDs. Samples are the final preps submitted for genotyping, sequencing, and/or expression data. For example, if one patient (subject ID) gave one sample, and that sample was processed differently to generate 2 sequencing runs, there would be two rows, both using the same subject ID, but having 2 unique sample IDs.
- This sample attributes table includes body site where sample was collected, analyte type, tumor status, sequencing center, funding source, TOPMed phase, project, and study name.
Similar models
Eligibility Criteria
- StudyEvent: SEV1
- Eligibility Criteria
- The subject consent data table contains subject IDs, consent group information, subject aliases, and subject's sex.
- This subject sample mapping data table includes a mapping of study subject IDs to sample IDs. Samples are the final preps submitted for genotyping, sequencing, and/or expression data. For example, if one patient (subject ID) gave one sample, and that sample was processed differently to generate 2 sequencing runs, there would be two rows, both using the same subject ID, but having 2 unique sample IDs.
- This sample attributes table includes body site where sample was collected, analyte type, tumor status, sequencing center, funding source, TOPMed phase, project, and study name.
C0680251 (UMLS CUI [1,2])
C2348563 (UMLS CUI [1,2])
C0030551 (UMLS CUI [1,2])
C0337471 (UMLS CUI [1,3])
C0004096 (UMLS CUI [1,2])
C1444637 (UMLS CUI [1,2])
C0010200 (UMLS CUI [1,3])
C0043144 (UMLS CUI [1,4])
C0013404 (UMLS CUI [1,5])
C0549184 (UMLS CUI [1,2])
C0549184 (UMLS CUI [1,2])
C1277691 (UMLS CUI [1,2])
C0543414 (UMLS CUI [2,1])
C5142833 (UMLS CUI [2,2])
C0332152 (UMLS CUI [1,2])
C0032981 (UMLS CUI [1,3])
C0024115 (UMLS CUI [1,2])
C0549184 (UMLS CUI [1,3])